Aggregation and thromboxane synthesis and release in isolated sheep neutrophils and lymphocytes in response to complement stimulation.

[1]  C. Rizzi.  Statistical Methods , 2020, Springer Theses.

[2]  M. Gee,et al.  Arachidonate cyclooxygenase metabolites as mediators of complement-initiated lung injury. , 1985, Federation proceedings.

[3]  M. Gee,et al.  Role of intrapulmonary release of eicosanoids and superoxide anion as mediators of pulmonary dysfunction and endothelial injury in sheep with intermittent complement activation. , 1983, Circulation research.

[4]  N. Roberts,et al.  Human alveolar macrophage support of lymphocyte responses to mitogens and antigens. Analysis and comparison with autologous peripheral-blood-derived monocytes and macrophages. , 1983, The American review of respiratory disease.

[5]  M. Gee,et al.  Role of prostaglandins and leukotrienes in complement-initiated lung vascular injury. , 1983, Chest.

[6]  M. Gee,et al.  Effects of anesthesia and surgery on prostanoid concentrations in plasma and pulmonary lymph. , 1983, Prostaglandins, leukotrienes, and medicine.

[7]  J. Cooper,et al.  Thromboxane Synthesis by Sources Other Than Platelets in Association with Complement‐Induced Pulmonary Leukostasis and Pulmonary Hypertension in Sheep , 1983, Circulation research.

[8]  Sun Js.  The leukocyte complement system. , 1982 .

[9]  H. Jacob,et al.  Complement-induced granulocyte aggregation in vivo. , 1981, The American journal of pathology.

[10]  B. Ware,et al.  Adhesion of leukocytes to endothelium: roles of divalent cations, surface charge, chemotactic agents and substrate. , 1980, Journal of cell science.

[11]  J. Cooper,et al.  Prostaglandin production associated with the pulmonary vascular response to complement activation. , 1980, Surgery.

[12]  A. Churg,et al.  Production of acute pulmonary injury by leukocytes and activated complement. , 1980, Surgery.

[13]  J. Cooper,et al.  Pulmonary Leukostasis and Its Relationship to Pulmonary Dysfunction in Sheep and Rabbits , 1980, Circulation research.

[14]  W. Stenson,et al.  Formation of thromboxane B2 and hydroxyarachidonic acids in purified human lymphocytes in the presence and absence of PHA. , 1979, Journal of immunology.

[15]  P. Ward,et al.  Desensitization of the neutrophil aggregation response to chemotactic factors. , 1978, The American journal of pathology.

[16]  G. Weissmann,et al.  Thromboxane generation by human peripheral blood polymorphonuclear leukocytes , 1978, The Journal of experimental medicine.

[17]  J. White,et al.  Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. , 1977, The Journal of clinical investigation.

[18]  Ian R. Tizard,et al.  An introduction to veterinary immunology , 1977 .

[19]  A. Kaplan,et al.  Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge. , 1975, The Journal of clinical investigation.

[20]  P. Ward,et al.  A neutrophil chemotactic factor from human C'5. , 1969, Journal of immunology.